Alkahest
A company developing anti-aging treatments using components derived from human blood.
3
Funding Rounds
$41.0m
Money raised
Alzheon
Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.
8
Funding Rounds
$92.7m
Money raised
Cerecin
Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
7
Funding Rounds
$189.5m
Money raised
Leucadia Therapeutics
Leucadia Therapeutics is a company working on Alzheimer's Disease.
1
Funding Rounds
Verge Genomics
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
5
Funding Rounds
$134.1m
Money raised
Neuraly
A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease.
1
Funding Rounds
$36.0m
Money raised
Altoida
Creating a New Gold Standard in Brain Health With Precision Neurology.
3
Funding Rounds
$26.3m
Money raised
Cytox Limited
Cytox Limited is a company founded in 2004 by Zsuzsanna Nagy.
7
Funding Rounds
$14.1m
Money raised
Neurotrack
Neurotrack is a company offering a memory health tracking platform founded in 2012.
4
Funding Rounds
$36.8m
Money raised
Muna Therapeutics
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases
2
Funding Rounds
$146.0m
Money raised
Avalon AI
Avalon AI is a London-based developer of a deep learning-based diagnostics tool for the detection of brain degenerative diseases.
1
Funding Rounds
Optina Diagnostics
Optina Diagnostics develops technology for the early detection of disease through the eye.
2
Funding Rounds
$24.1m
Money raised
Linus Health
Linus Health is a company founded in 2019.
1
Funding Rounds
$55.0m
Money raised
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
4
Funding Rounds
$351.6m
Money raised
Amyl Therapeutics
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
3
Funding Rounds
$33.6m
Money raised
Wren Therapeutics
Wren Therapeutics is a small Molecules Targeting Protein Mis-Folding founded in 2016 by Chris Dobson.
2
Funding Rounds
$40.4m
Money raised
AlphaCognition
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
4
Funding Rounds
$12.3m
Money raised
T3D Therapeutics
T3D Therapeutics is a company developing drug therapy for Alzheimer's disease founded by John Didsbury.
3
Funding Rounds
$30.4m
Money raised
Shape Therapeutics
Shape Therapeutics is a RNA-editing gene therapy.
2
Funding Rounds
$147.5m
Money raised
EIP Pharma
EIP Pharma is an alzheimer's treatment founded by Sylvie Gregoire.
3
Funding Rounds
$36.2m
Money raised
Neurodon
Neurodon is a biopharmaceutical company focusing on Alzheimer's disease founded by Russell Dahl.
1
Funding Rounds
$500.0k
Money raised
TauRx Pharmaceuticals
A company deveoping treatments for Alzheimer's disease and other neurological conditions
3
Funding Rounds
$257.5m
Money raised
Asceneuron
Asceneuron is a clinical-stage biotech company.
1
Funding Rounds
$100.0m
Money raised
Cognos Therapeutics
Cognos Therapeutics creates technologies to advance the diagnosis and treatment of neuropathic diseases.
2
Funding Rounds
$2.7m
Money raised
reMYND
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
1
Funding Rounds
$14.5m
Money raised
AltPep Corp
Alternating Peptides for Neurological Diseases
3
Funding Rounds
$99.1m
Money raised
Valted Seq
Valted Seq is a sequencing Data.
1
Funding Rounds
$10.0m
Money raised